NCT01261143

Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

Phase III Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 164 (estimated)
• Sponsor: Bukwang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the: Primary end point * change of Total symptom score Secondary end point * neurological test

Detailed description

total symptom score shall be calculated from the data of burning, numbness, stabbing pain, paraesthesiae.

Conditions

• Diabetic Neuropathies

Interventions

Type	Name	Description
DRUG	BK-C-0701	tablet, 8 weeks

Timeline

• Start date: 2010-08-01
• Primary completion: 2012-04-01
• First posted: 2010-12-16
• Last updated: 2012-04-25

Locations

1 site across 1 country: South Korea